Logo image
Revascularization and Heart Failure
Book chapter

Revascularization and Heart Failure

John W. C. Entwistle and Andrew S. Wechsler
Heart Failure, pp 403-425
22 Feb 2017

Abstract

Heart failure Ischemic cardiomyopathy Mechanical dyssynchrony Myocardial viability Revascularization
The management of patients with ischemic cardiomyopathy involves evaluation of the relative benefits of revascularization versus medical management, or the referral for advanced heart failure therapies. While the decision to proceed with revascularization may be straight-forward in patients with severe angina or important stenosis of the left main coronary artery, many patients have less clear indications for revascularization and require additional evaluation. Viability testing, assessment of hemodynamics or evaluation of mechanical dyssynchrony can provide information that may help define the relative risks of revascularization and medical management. Even in the situation where the operative risk is elevated, it may still be less than the risk of non-operative therapy. When faced with a patient with very high operative risk, one should consider alternative approaches such as cardiac transplantation or the use of long-term ventricular assist devices.

Metrics

8 Record Views

Details

Logo image